纳比克西莫尔口腔粘膜喷雾剂 (Sativex®) 对与多发性硬化症相关的性相关的症状的影响:一个案例系列
1Neurozentrum Hannover, Hannover, Germany.
Drugs in context
|February 22, 2024
概括
四大麻素-大麻二醇 (纳比西莫尔) 喷雾改善了多发性硬化症 (MS) 和相关症状,如疼痛和睡眠障碍. 这种治疗提供了好处,不仅仅是减少MS患者的性.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 性和相关症状在多发性硬化症 (MS) 中很普遍.
- 这些症状,包括,疼痛,睡眠障碍和膀功能障碍,可以相互联系.
- 传统的口服药物可能无法充分解决中度至重度的MS性.
研究的目的:
- 在辅助纳比西莫尔治疗期间,描述MS性成年人的症状演变.
- 评估四大麻素-大麻二醇 (纳比西莫尔) 对多发性硬化患者的性和相关症状的疗效.
- 评估纳比西莫尔的益处是否超出了减轻性的范围.
主要方法:
- 一个涉及12名患有MS性的成年患者的病例系列.
- 在添加纳比克西莫尔或粘菌喷雾治疗之前和期间评估症状严重程度.
- 评估性,,步行距离,疼痛,睡眠障碍和膀功能障碍.
主要成果:
- 纳比西莫尔在11名患者中降低了性严重程度,其中8人显示出临床上重要的改善.
- 在7名患者中,的严重程度降低或消失.
- 在步行距离 (8名患者),疼痛严重程度 (11名患者),睡眠障碍 (12名患者) 和膀功能障碍 (7名患者中6名患者) 中观察到改善.
- 两名患者出现了不良反应或有限的反应.
结论:
- 辅助纳比西莫尔治疗可以有效地减少MS性.
- 纳比西莫尔对性相关症状有好处,包括疼痛,睡眠障碍和膀功能障碍.
- 个体患者水平的数据表明,纳比西莫尔在MS中提供了更广泛的症状缓解.
相关概念视频
Skeletal Muscle Relaxants: Therapeutic Uses
486
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
486
Centrally Acting Muscle Relaxants: Therapeutic Uses
688
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
688
Classification of Skeletal Muscle Relaxants
2.5K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.5K
Spasmolytic Agents: Chemical Classification
883
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
883
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
3.3K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
3.3K
Skeletal Muscle Relaxants: Adverse Effects
372
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
372


